Spinal Cord Stimulation Market and Globus’ Acquisition of Nevro
The spinal cord stimulation (SCS) market is undergoing a significant transformation, driven by technological advancements and an increasing demand for non-pharmacological solutions to chronic pain. With rising concerns about opioid use and side effects, the adoption of spinal cord stimulation devices has surged as a safer, drug-free alternative. For more details visit https://issuu.com/lifesciencem....arketresearch/docs/s